Rodriguez, L., Herrero-Garcia, J., Santamaria, X., Pardo-Figuerez, M., Gonzalez Fernandez, J., Querol, S., . . . Gonzalez Junyent, C. (2025). Autologous cell therapy with CD133+ bone marrow-derived stem cells for Asherman Syndrome: A phase 1/2 trial.
Citación estilo ChicagoRodriguez, Luciano, Julio Herrero-Garcia, Xavier Santamaria, Maria Pardo-Figuerez, Javier Gonzalez Fernandez, Sergio Querol, DAVID VALCARCEL, y Carla Gonzalez Junyent. Autologous Cell Therapy With CD133+ Bone Marrow-derived Stem Cells for Asherman Syndrome: A Phase 1/2 Trial. 2025.
Cita MLARodriguez, Luciano, et al. Autologous Cell Therapy With CD133+ Bone Marrow-derived Stem Cells for Asherman Syndrome: A Phase 1/2 Trial. 2025.
Precaución: Estas citas no son 100% exactas.